Y.S.P. SOUTHEAST ASIA HOLDING |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.47 MYR | 0.00% |
|
+1.65% | +7.39% |
| Sales 2021 | 282M 59.03M | Sales 2022 | 334M 70M | Capitalization | 360M 75.32M |
|---|---|---|---|---|---|
| Net income 2021 | 15M 3.14M | Net income 2022 | 34M 7.12M | EV / Sales 2021 | 0.68 x |
| Net cash position 2021 | 80.11M 16.78M | Net cash position 2022 | 103M 21.59M | EV / Sales 2022 | 0.77 x |
| P/E ratio 2021 |
17.9
x | P/E ratio 2022 |
10.4
x | Employees | - |
| Yield 2021 |
3.63% | Yield 2022 |
2.94% | Free-Float | 33.8% |
More Fundamentals
* Assessed data
More news
| 1 week | +1.65% | ||
| Current month | +0.82% | ||
| 1 month | +2.49% | ||
| 3 months | +6.01% | ||
| 6 months | -0.80% | ||
| Current year | +7.39% |
1 week
2.41
2.47
1 month
2.412.47
Current year
2.292.47
1 year
2.262.61
3 years
1.882.92
5 years
1.453.05
10 years
1.193.49
| Managers | Title | Age | Since |
|---|---|---|---|
Fang Hsin Lee
CEO | Chief Executive Officer | 64 | 03-11-16 |
Siew Wai Yap
SAM | Sales & Marketing | 54 | 96-12-31 |
Mei Kee Kong
SEC | Corporate Secretary | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ling Chin Lee
BRD | Director/Board Member | 75 | 05-02-15 |
Fang Hsin Lee
CEO | Chief Executive Officer | 64 | 03-11-16 |
Anis bin Ahmad
CHM | Chairman | 78 | 02-09-15 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 2.47 | 0.00% | 7,500 |
| 24-04-24 | 2.47 | +0.82% | 28,600 |
| 24-04-23 | 2.45 | +1.66% | 103,400 |
| 24-04-22 | 2.41 | -1.23% | 14,000 |
| 24-04-19 | 2.44 | +0.41% | 35,600 |
End-of-day quote BURSA MALAYSIA, April 24, 2024
More quotes
Y.S.P. Southeast Asia Holding Berhad is a Malaysia-based pharmaceutical company. The Company provides a range of pharmaceutical, over-the-counter (OTC), veterinary and aquatic products. The Company's segments include Manufacturing, Trading and Investment holding. The Manufacturing segment is engaged in the manufacturing of pharmaceutical products. The Trading segment is involved in the import, export and trading of various kinds of pharmaceutical, traditional herbal and veterinary products. The Company is engaged in investment holding and provision of management services. Its subsidiaries include Y.S.P. (Cambodia) Pte. Ltd., which provides management services in respect of product registration, trademark registration and national marketing and trading in all kinds of pharmaceutical products, and Alpha Active Industries Sdn. Bhd., which is engaged in the manufacturing of biotechnology products and health products.
Sector
Pharmaceuticals
Calendar
2024-05-20
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +7.39% | 73.33M | |
| +19.87% | 22.25B | |
| +13.49% | 14.39B | |
| +13.38% | 13.55B | |
| +38.75% | 11.27B | |
| -9.00% | 6.95B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +6.35% | 5.01B | |
| -5.36% | 4.51B |
- Stock Market
- Equities
- YSPSAH Stock
